BioNTech Q4 Profit Down On Weak Revenues; Sees FY23 COVID-19 Vaccine Revenues Of €5 Bln

German biotechnology company BioNTech SE (BNTX) reported Monday that its fourth-quarter net profit was 2.28 billion euros, lower than last year's 3.17 billion euros.

Earnings per share fell to 9.26 euros from 12.18 euros a year ago.

Total revenues for the quarter were 4.28 billion euros, down from prior year's 5.53 billion euros. The company said the change corresponds with the demand for COVID-19 vaccines.

Looking ahead for fiscal 2023, estimated BioNTech COVID-19 vaccine revenues would be around 5 billion euros.

BioNTech said the revenue estimate reflects expected revenues related to its share of gross profit from COVID-19 vaccine sales in the collaboration partner's territories, and from direct COVID-19 vaccine sales to customers in BioNTech's territory. It also includes expected revenues from sales to collaboration partners which may be influenced by costs like inventory write-offs once materialized and shared with the collaboration partner Pfizer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
GameStop Corp. Wednesday disclosed that its Board of Directors has elected Chairman Ryan Cohen as Executive Chairman, effective immediately. In a filing with the U.S. Securities and Exchange Commission, the video game retailer said its Board on June 5 terminated Matthew Furlong as President and Chief Executive Officer with immediate effect. Shares of Inditex SA were gaining around 6 percent in the morning trading in Spain after the clothing firm that owns Zara reported Wednesday significant growth in its first-quarter profit on higher revenues as well as the absence of a prior year provision. Regarding the second quarter to date, the company said its store and online sales in constant currency between May 1 and June 4 increased 16.. The U.S. Consumer Product Safety Commission or CPSC, along with Golden, Colorado-based Boppy Co., urged consumers to stop using recalled Boppy Newborn Loungers, following reports of more infant deaths. They also asked online marketplaces to stop selling the recalled product. The company in September 2021 had recalled over 3.3 million infant lounging pillows after it was connected with deaths of 8
Follow RTT